The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

Clinical trial NCT03830671 · COMPLETED

Trial details

NCT number: NCT03830671
Sponsor: Beijing Chest Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multi-drug Resistant Tuberculosis

Start date: 2019-03-08
Primary completion: 2022-06-08
Enrollment: 515

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.